Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine – Genetic Literacy Project
Genetic Literacy Project |
Former Novartis chief Joseph Jimenez discusses breakthroughs in gene therapy, future of CRISPR in medicine
Genetic Literacy Project Editor's Note: Novartis CEO Joseph Jimenez retired in January after eight years in the top job at one of the world's top pharmaceutical companies. During his tenure, the company helped lead a movement that put gene therapies on the map. Scientific … |
